Physician profile
Christopher D Oneill
NPI 1134120470
$480.25
in general payments reported to CMS, 2019-2025
5 companies · $16.27 in 2025
The $16.27 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.00 · 2023: $381 · 2024: $69.93 · 2025: $16.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $381 · Food and Beverage: $86.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $381.05 |
| Food and Beverage | $86.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $381.05 | 2023 | Impella |
| Glaukos Corporation | $43.21 | 2024 | Idose |
| Takeda Pharmaceuticals U.S.A., INC. | $26.72 | 2024 | Gattex |
| Merck Sharp & Dohme LLC | $16.27 | 2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.